Variant report
Variant | nsv982188 |
---|---|
Chromosome Location | chr9:47190-63021 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DOCK8-6 | chr9:62716-62816 | NONHSAT129888 |
2 | lnc-DOCK8-6 | chr9:62698-62816 | ucscGeneNc_uc003zfx_2 |
3 | lnc-DOCK8-6 | chr9:62701-62816 | NONHSAT129886 |
4 | lnc-DOCK8-6 | chr9:62706-62816 | NONHSAT129887 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4741796 | chr9:47217-47218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9407063 | chr9:47242-47243 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs541802458 | chr9:47244-47245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561435587 | chr9:47276-47277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9407064 | chr9:47303-47304 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs181248323 | chr9:47318-47319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9408289 | chr9:47352-47353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532729087 | chr9:47366-47367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547620686 | chr9:47373-47374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200738096 | chr9:47395-47396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566154274 | chr9:47458-47459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148668613 | chr9:47459-47460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370646707 | chr9:47488-47489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375114732 | chr9:47535-47536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536913695 | chr9:47557-47558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558414355 | chr9:47576-47577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559301988 | chr9:48460-48461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577420088 | chr9:48464-48465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113606208 | chr9:48465-48466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376921346 | chr9:48467-48468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541286899 | chr9:48499-48500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12353065 | chr9:48515-48516 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs559863223 | chr9:48544-48545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530217434 | chr9:48558-48559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9408297 | chr9:48559-48560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542338878 | chr9:48562-48563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563440619 | chr9:48596-48597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138825825 | chr9:48609-48610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552114471 | chr9:48626-48627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570419553 | chr9:48666-48667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528361830 | chr9:48672-48673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186491795 | chr9:48673-48674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568270943 | chr9:48679-48680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139803529 | chr9:48728-48729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557132385 | chr9:48758-48759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201220995 | chr9:48779-48780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10453203 | chr9:48789-48790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62531206 | chr9:48798-48799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62531207 | chr9:48827-48828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10453175 | chr9:48834-48835 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs541745082 | chr9:48866-48867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553369502 | chr9:48869-48870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10453176 | chr9:48914-48915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375868389 | chr9:48952-48953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10453177 | chr9:48962-48963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542010603 | chr9:48978-48979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563453074 | chr9:48992-48993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530869481 | chr9:48996-48997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545817932 | chr9:49037-49038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561904268 | chr9:49039-49040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164920 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:46200-47600 | Enhancers | K562 | blood |
2 | chr9:48400-52400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:52400-53400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr9:52600-53000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr9:62000-62200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr9:62200-63000 | Enhancers | Fetal Thymus | thymus |
7 | chr9:62800-63000 | Enhancers | Dnd41 | blood |
8 | chr9:63000-63200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
9 | chr9:63000-63200 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
10 | chr9:63000-63200 | Flanking Active TSS | Fetal Thymus | thymus |
11 | chr9:63000-63200 | Flanking Active TSS | Dnd41 | blood |
12 | chr9:63000-63400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr9:63000-63400 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr9:63000-63400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
15 | chr9:63000-63600 | Enhancers | Primary T cells fromperipheralblood | blood |
16 | chr9:63000-63600 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
17 | chr9:63000-63600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr9:63000-63600 | Enhancers | Fetal Lung | lung |
19 | chr9:63000-64000 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr9:63000-64200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |